AVTX in the 13F filings
Avalo Therapeutics Inc · CUSIP 05338F306
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 15,511,219
- combined, among listed positions
- Reported value
- $287m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 17 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +8,225,799.
Managers listing AVTX in Q2 2026
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 5,100,216 shares now+2,220,735
- Farallon Capital Management LLCexisting position · 2,498,000 shares now+1,582,000
- Point72 Asset Management LPexisting position · 2,387,026 shares now+1,470,884
- T. Rowe Price Associates Incnew position · 1,311,715 shares now+1,311,715
- AllianceBernstein LPnew position · 1,260,689 shares now+1,260,689
Reductions
- Man Group PLCexisting position · 36,876 shares now-9,677
- ExodusPoint Capital Management LPexisting position · 16,495 shares now-1,256
New positions and exits
New (9)
Exited (5)
- Millennium Management LLCwas $12m
- Jane Street Group LLCwas $2.6m
- Hudson Bay Capital Management LPwas $2.4m
- Marshall Wace LLPwas $1.9m
- Brevan Howard Capital Management LPwas $288k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2026 | 1 | $14m | 10 | 9 |
| Q2 2026 | 2 | $90m | 17 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AVTX and LLY →AVTX and JNJ →AVTX and VRTX →Choose a stock to compare with AVTX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AVTX, latest filings →Back to the 13F Explorer →